Phase 1 Light Chain (AL) Amyloidosis Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

Immunoglobulin Light Chain (AL) Amyloidosis

AbbVie76 enrolled21 locationsNCT06158854

Recruiting

Phase 1Phase 2

Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

Light Chain (AL) Amyloidosis

Nexcella Inc.40 enrolled18 locationsNCT06097832